NextCure NXTC
NASDAQ NXTC
$4.71 -0.70 (-13.21%)
As of: Oct 22, 2026 · 3:59 PM EDT

NextCure (NXTC) Selling, General & Administrative (2018 - 2026)

Updated

NextCure's Selling, General & Administrative came in at $2.59 million for Q2 2026, down 19.0% from $3.2 million a year earlier and down 20.8% from the prior quarter.

Analysis

NextCure (NXTC) Selling, General & Administrative (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, NextCure reported Selling, General & Administrative of $11.63 million, down 18.1% year-over-year; for FY2025, it was $12.69 million, down 19.2% from FY2024.

  • Selling, General & Administrative has declined in each of the last three years, with a five-year compound annual growth rate of -5.7% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $15.72 million in FY2024 (-20.2%), $19.71 million in FY2023 (-9.2%), $21.71 million in FY2022 (+5.5%) and $20.57 million in FY2021 (+20.7%).
  • The Q2 2026 figure represents the lowest quarterly Selling, General & Administrative since Q1 2019.
  • Year-over-year, Selling, General & Administrative has declined for 12 consecutive quarters, with an average decline of 17.3% over the last eight quarters.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q1 2022 (growth of 18.5%), and the weakest in Q2 2024 (a decline of 28.6%).
  • Business Quant data shows NXTC's Selling, General & Administrative at $3.27 million (Q1 2026), $2.96 million (Q4 2025) and $2.81 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 6.29 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 3.63 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 5.65 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 1.92 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 3.41 Bn
10 NextCure 25.27 Mn -95.48 Mn - 2.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.59 Mn
Mar 31, 2026 3.27 Mn
Dec 31, 2025 2.96 Mn
Sep 30, 2025 2.81 Mn
Jun 30, 2025 3.20 Mn
Mar 31, 2025 3.73 Mn
Dec 31, 2024 3.55 Mn
Sep 30, 2024 3.73 Mn
Jun 30, 2024 4.08 Mn
Mar 31, 2024 4.36 Mn
Dec 31, 2023 3.96 Mn
Sep 30, 2023 4.61 Mn
Jun 30, 2023 5.71 Mn
Mar 31, 2023 5.42 Mn
Dec 31, 2022 4.95 Mn
Sep 30, 2022 5.71 Mn
Jun 30, 2022 5.30 Mn
Mar 31, 2022 5.75 Mn
Dec 31, 2021 4.81 Mn
Sep 30, 2021 4.91 Mn
API Access

NextCure Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NXTC&period=max&api_key=YOUR_API_KEY